Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 7;7(4):626-636.
doi: 10.1002/ags3.12659. eCollection 2023 Jul.

Postoperative complications and prognosis based on type of surgery in ulcerative colitis patients with colorectal cancer: A multicenter observational study of data from the Japanese Society for Cancer of the Colon and Rectum

Affiliations

Postoperative complications and prognosis based on type of surgery in ulcerative colitis patients with colorectal cancer: A multicenter observational study of data from the Japanese Society for Cancer of the Colon and Rectum

Nobuaki Hoshino et al. Ann Gastroenterol Surg. .

Abstract

Background: Patients with ulcerative colitis are reported to be at increased risk of colorectal cancer and are also at high risk of postoperative complications. However, the incidence of postoperative complications in these patients and how the type of surgery performed affects prognosis are not well understood.

Methods: Data collected by the Japanese Society for Cancer of the Colon and Rectum on ulcerative colitis patients with colorectal cancer between January 1983 and December 2020 were analyzed according to whether total colorectal resection was performed with ileoanal anastomosis (IAA), ileoanal canal anastomosis (IACA), or permanent stoma creation. The incidence of postoperative complications and the prognosis for each surgical technique were investigated.

Results: The incidence of overall complications was not significantly different among the IAA, IACA, and stoma groups (32.7%, 32.3%, and 37.7%, respectively; p = 0.510). The incidence of infectious complications was significantly higher in the stoma group (21.2%) than in the IAA (12.9%) and IACA (14.6%) groups (p = 0.048); however, the noninfectious complication rate was lower in the stoma group (13.7%) than in the IAA (21.1%) and IACA (16.2%) groups (p = 0.088). Five-year relapse-free survival was higher in patients without complications than in those with complications in the IACA group (92.8% vs. 75.2%; p = 0.041) and the stoma group (78.1% vs. 71.2%, p = 0.333) but not in the IAA group (90.3% vs. 90.0%, p = 0.888).

Conclusion: The risks of infectious and noninfectious complications differed according to the type of surgical technique used. Postoperative complications worsened prognosis.

Keywords: colorectal neoplasms; postoperative complication; prognosis; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest for this article.

Figures

FIGURE 1
FIGURE 1
Flow diagram showing the patient selection process. IAA, ileoanal anastomosis; IACA, ileoanal canal anastomosis; JSCCR, Japanese Society for Cancer of the Colon and Rectum; UC, ulcerative colitis.
FIGURE 2
FIGURE 2
Five‐year overall survival and recurrence‐free survival for each surgical procedure according to presence or absence of overall complications. IAA, ileoanal anastomosis; IACA, ileoanal canal anastomosis; OS, overall survival; RFS, relapse‐free survival.
FIGURE 3
FIGURE 3
Five‐year overall survival and recurrence‐free survival for each surgical procedure according to presence or absence of infectious complications. IAA, ileoanal anastomosis; IACA, ileoanal canal anastomosis; OS, overall survival; RFS, relapse‐free survival.
FIGURE 4
FIGURE 4
Five‐year overall survival and recurrence‐free survival for each surgical procedure according to presence or absence of noninfectious complications. IAA, ileoanal anastomosis; IACA, ileoanal canal anastomosis; OS, overall survival; RFS, relapse‐free survival.

Similar articles

References

    1. Ungaro R, Mehandru S, Allen PB, Peyrin‐Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756–70. - PMC - PubMed
    1. Biondi A, Zoccali M, Costa S, Troci A, Contessini‐Avesani E, Fichera A. Surgical treatment of ulcerative colitis in the biologic therapy era. World J Gastroenterol. 2012;18:1861–70. - PMC - PubMed
    1. Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, et al. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of inflammatory bowel diseases consensus. Lancet Gastroenterol Hepatol. 2022;7:666–78. - PubMed
    1. Ferretti F, Cannatelli R, Monico MC, Maconi G, Ardizzone S. An update on current pharmacotherapeutic options for the treatment of ulcerative colitis. J Clin Med. 2022;11:2302. - PMC - PubMed
    1. Bohl JL, Sobba K. Indications and options for surgery in ulcerative colitis. Surg Clin North Am. 2015;95:1211–32. - PubMed